# OnCo record nct06639347 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06639347/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06639347", "NCT06639347" ;
  schema:name "A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma"@en ;
  schema:description "A phase 1/2 trial of SHR-A2102, Adebrelimab and SHR-8068 in bladder & urothelial cancer, run by Shanghai Hengrui Pharmaceutical Co., Ltd., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06639347/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06639347> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2024-11-04" ;
  onco:cancers <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/muscle-invasive-bladder-cancer/> ;
  onco:drugs <https://onco.cc/drugs/shr-a2102/>, <https://onco.cc/drugs/adebrelimab/>, <https://onco.cc/drugs/shr-8068/> ;
  onco:companies <https://onco.cc/companies/hengrui/> .